Three disruptive technology fund applicants split €28.2m

Selected projects to deliver better cancer treatment, cardiac care, and improve driving

Trade

Image: Shutterstock

Three projects have received a combined €28.2 million under Call 7 of the Disruptive Technologies Innovation Fund (DTIF).

In the largest award to date under the DTIF, €12 million was secured for the N-LIFT project which aims to overcome treatment resistance in advanced or metastatic solid tumours that are no longer responding to therapy. The consortium of Lift BioSciences, Hooke Bio and University of Galway will advance the N-LIfT platform to launch the first human trial of IMAN therapy, targeting treatment-resistant advanced solid tumours.

A second project, Ventripump, was awarded €9.3 million which aims to develop this comprehensive medical device platform to treat cardiogenic shock, which will be the first significant innovation in a market where mortality rates have remained too high over the past few decades. The consortium of CardiacBooster, Integer Holdings and Fire1, will develop and validate Ventripump as the gold standard specification to treat cardiogenic shock. This project holds significant promise for improving health outcomes and preventing loss of life.

A third project, MIMRAD 5D, was awarded €6.9 million in funding which will result in safer driving outcomes. The consortium of Provizio, Robert Bosch Ireland and University of Limerick will develop a compact, cost-effective imaging radar design combining AI perception, transceivers, and sensor fusion expertise for an Advanced Driver Assistance Systems (ADAS).

Jenny Melia, CEO, Enterprise Ireland, said: “The Disruptive Technologies Innovation Fund is about investing in bold ideas and ambitious partnerships that have the potential to deliver real impact – for our economy and for our society. The three projects announced today exemplify this ambition, with breakthroughs in cancer treatment, cardiac care and road safety that could save lives and transform global markets.

“Through the DTIF, we are supporting dynamic Irish companies to develop new intellectual property and to scale world-class innovation. The collaborative model is helping to anchor R&D talent in regions across the country and build strong foundations for future growth. Enterprise Ireland is proud to play a central role in delivering this programme, which continues to unlock transformative opportunities for Irish enterprise.”

A further DTIF Call will be announced later this year.

TechCentral Reporters

Read More: Disruptive Technologies Innovation Fund DTIF Enterprise Ireland